Details: Randomized, double-blind, placebo-controlled trial involving 338 outpatients with MDD, conducted over an 8-week monotherapy period (250mg BID). Initial results from the OLIVE trial are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback